CARP
2004
Coronary Artery Revascularization Prophylaxis trial
In 510 patients with stable coronary artery disease scheduled for elective major vascular surgery, prophylactic coronary revascularisation before surgery did not reduce long-term all-cause mortality or postoperative myocardial infarction compared with no preoperative revascularisation.
Result
Efficacy: Long-term all-cause mortality (median follow-up 2.7 years)relative risk 0.98 (95% CI 0.70-1.37) · P = 0.92
Below 1 favours prophylactic coronary revascularisation before surgery, above 1 favours no preoperative revascularisation.
- Absolute difference
- 1 points
The absolute difference is derived from the event rates.
Also reported: Postoperative MI within 30 days 12 % vs 14 % (p=0.37). Surgery was delayed by a median 54 vs 18 days.
- Subtopic
- Preoperative revascularisation
- Design
- Open-label RCT
- Relevance
- Important: one of several pillars.
- Source
- McFalls EO, Ward HB, Moritz TE, et al. N Engl J Med. 2004;351(27):2795-2804.doi 10.1056/NEJMoa041905
Discussion & critique
Highly selected: only 9 % of screened patients were randomised, and left main disease and severe LV dysfunction were excluded, so it says nothing about the highest-risk anatomies. Within stable coronary disease it is definitive and is why routine prophylactic revascularisation before non-cardiac surgery is not recommended.